ZNF671 Methylation Test in Cervical Scrapings for Cervical Intraepithelial Neoplasia Grade 3 and Cervical Cancer Detection.

Peng Zhu,Jing Xiong,Ding Yuan,Xiang Li,Lili Luo,Ju Huang,Binbin Wang,Quanfang Nie,Shuli Wang,Liying Dang,Yan Chen,Shu Li,Yuhan An,Li Yang,Rong Liu,Yanping He,Xiong Li,Puxiang Chen,Honghao Zhou,Qing Li

DOI: https://doi.org/10.1016/j.xcrm.2023.101143

IF: 16.988

2023-01-01

Cell Reports Medicine

Abstract:Effective triage of high-risk human papillomavirus (hrHPV)+ women is warranted to avoid unnecessary referral and overtreatment. Molecular triage tests have recently begun to impact cervical intraepithelial neoplasia grade 3 (CIN3) or cervical cancer (CC), termed CIN3+, detection. We find that zinc finger pro-tein 671 methylation (ZNF671m) test has superior performance for CIN3+ detection in all single molecular triage tests, including HPV16/18 genotyping, paired box gene 1 methylation (PAX1m), and ZNF671m, in the training set. Using ZNF671m test instead of Thinprep cytologic test (TCT) as a single triage strategy or as a combined triage strategy with HPV16/18 genotyping has achieved comparable sensitivity but higher specificity for CIN3+ detection among 391 hrHPV+ women in the validation set. Little attention has been paid to the women with hrHPV- status but detected CIN3+. We find that the CIN3+ risk after a nega-tive result could be reduced further by triage using ZNF671m in hrHPV- patients.